SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?


To: patlawche11 who wrote (46439)6/6/2018 1:48:40 PM
From: Going_2_Disney_World  Read Replies (1) | Respond to of 63277
 
This looks like the Phase 2 they announced about a week ago, before ASCO.

finance.yahoo.com

G2DW



To: patlawche11 who wrote (46439)8/24/2018 4:36:43 PM
From: patlawche111 Recommendation

Recommended By
erippetoe

  Read Replies (1) | Respond to of 63277
 
Updated Presentation

Slide 36 - Cash Balance as of 6/30/2018 is $639 Million, and debt of $20 Million

immunomedics.com



To: patlawche11 who wrote (46439)10/31/2018 9:45:25 AM
From: patlawche1110 Recommendations

Recommended By
captcobra1
CelebrityEquity
corndog
dorightbythem
drtom1234

and 5 more members

  Read Replies (1) | Respond to of 63277
 
New Trial posted today (PII) - IMMU-132 in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy

clinicaltrials.gov